0,848  0,005  Antineoplastic (breast cancer)
0,782  0,004  Antineoplastic (pancreatic cancer)
0,778  0,014  Caspase 9 stimulant
0,766  0,005  Prostate cancer treatment
0,750  0,013  Antineoplastic (lung cancer)
0,707  0,014  Antineoplastic (colorectal cancer)
0,702  0,013  Antineoplastic (colon cancer)
0,670  0,015  CYP2C9 substrate
0,657  0,008  Cardiovascular analeptic
0,650  0,011  Sensitization
0,634  0,015  Respiratory analeptic
0,628  0,009  NOS3 expression inhibitor
0,623  0,006  UGT1A4 substrate
0,616  0,013  CYP2C19 substrate
0,625  0,026  CYP3A4 substrate
0,580  0,008  FMO1 substrate
0,588  0,027  TNF expression inhibitor
0,546  0,004  Contraceptive
0,561  0,024  Aldehyde oxidase inhibitor
0,569  0,035  Transcription factor NF kappa B inhibitor
0,550  0,018  Analeptic
0,558  0,030  GST A substrate
0,540  0,016  AR expression inhibitor
0,542  0,021  Antipruritic, allergic
0,539  0,019  CYP1A2 substrate
0,538  0,023  Immunosuppressant
0,566  0,057  Apoptosis agonist
0,515  0,009  UGT2B4 substrate
0,521  0,018  UGT1A9 substrate
0,545  0,070  Antiinflammatory
0,500  0,027  5 Hydroxytryptamine release stimulant
0,467  0,003  UGT2B9 substrate
0,490  0,029  Antineoplastic (ovarian cancer)
0,459  0,004  Antiinfertility, female
0,463  0,010  Antineoplastic (sarcoma)
0,474  0,025  CTGF expression inhibitor
0,471  0,022  NOS2 expression inhibitor
0,461  0,012  Antimutagenic
0,482  0,035  Cholesterol antagonist
0,475  0,028  Cytotoxic
0,462  0,016  UGT1A6 substrate
0,470  0,027  Antifungal
0,468  0,036  Teratogen
0,433  0,006  Acaricide
0,459  0,035  Embryotoxic
0,440  0,031  Cardioprotectant
0,430  0,025  Chemopreventive
0,417  0,013  Abortion inducer
0,410  0,008  UGT2B15 substrate
0,451  0,051  5 Hydroxytryptamine release inhibitor
0,405  0,009  Pneumotoxic
0,406  0,009  Antipruritic, non-allergic
0,433  0,041  Bone diseases treatment
0,409  0,019  UDP-glucuronosyltransferase substrate
0,392  0,012  UGT2B7 substrate
0,398  0,019  FMO3 substrate
0,386  0,010  Lipocortins synthesis antagonist
0,389  0,014  GST M1-1 substrate
0,378  0,005  Contraceptive male
0,389  0,020  Sodium/bile acid cotransporter inhibitor
0,381  0,013  Melanin inhibitor
0,378  0,010  Alpha-N-acetylglucosaminidase inhibitor
0,374  0,010  Protein kinase stimulant
0,396  0,042  ICAM1 expression inhibitor
0,353  0,006  SULT1A3 substrate
0,377  0,033  Proliferative diseases treatment
0,369  0,029  Nitric oxide antagonist
0,396  0,065  Antileukemic
0,367  0,040  Calcium channel activator
0,365  0,039  Cytostatic
0,375  0,049  CYP2D6 substrate
0,367  0,042  Antioxidant
0,388  0,064  Ulceration
0,338  0,014  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,398  0,078  Antibacterial
0,348  0,030  Antiulcerative
0,354  0,036  Antineoplastic (osteosarcoma)
0,351  0,033  Vascular (periferal) disease treatment
0,359  0,042  Chemoprotective
0,332  0,016  Interferon gamma antagonist
0,319  0,004  UGT2B10 substrate
0,331  0,018  Antiacne
0,346  0,033  Flavin-containing monooxygenase substrate
0,333  0,027  Anesthetic general
0,335  0,030  5 Hydroxytryptamine uptake stimulant
0,337  0,033  DNA synthesis inhibitor
0,328  0,026  UGT1A1 substrate
0,339  0,042  Free radical scavenger
0,332  0,042  Hypoglycemic
0,345  0,058  Apoptosis antagonist
0,322  0,038  Antiparasitic
0,326  0,041  Carcinogenic
0,338  0,054  Antihypercholesterolemic
0,290  0,006  SULT1A1 substrate
0,391  0,109  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,328  0,047  Antineoplastic (endocrine cancer)
0,302  0,029  P-glycoprotein inhibitor
0,322  0,050  Antihypoxic
0,302  0,031  RNA-directed DNA polymerase inhibitor
0,299  0,030  Hepatoprotectant
0,299  0,030  Antihypotensive
0,350  0,086  GABA C receptor rho-3 antagonist
0,302  0,038  Antihypertriglyceridemic
0,284  0,023  Neurotrophic factor enhancer
0,273  0,013  Antifungal enhancer
0,295  0,037  Antiparkinsonian, rigidity relieving
0,280  0,024  Carcinogenic, group 3
0,354  0,098  Histamine release inhibitor
0,314  0,059  Hypoxia-inducible factor 1 alpha inhibitor
0,281  0,031  Eye irritation, high
0,267  0,019  GST P1-1 substrate
0,254  0,006  Antirickettsial
0,260  0,013  Antineoplastic antibiotic
0,251  0,005  Arachidonic acid antagonist
0,317  0,074  Vasodilator, coronary
0,316  0,074  Hepatic disorders treatment
0,313  0,072  Caspase 3 stimulant
0,258  0,018  Heat shock protein 90 antagonist
0,248  0,009  Microtubule formation inhibitor
0,243  0,004  Adenylate cyclase stimulant
0,290  0,053  Interleukin agonist
0,247  0,013  UDP-glucose 4-epimerase inhibitor
0,307  0,075  Antineoplastic (brain cancer)
0,261  0,028  UGT1A3 substrate
0,258  0,027  Skin irritative effect
0,287  0,056  Superoxide dismutase inhibitor
0,276  0,048  Mutagenic
0,274  0,048  Tyrosine 3 hydroxylase inhibitor
0,241  0,019  Cholesterol synthesis inhibitor
0,259  0,042  Antihelmintic
0,248  0,032  Antihelmintic (Nematodes)
0,276  0,061  Antineoplastic (liver cancer)
0,220  0,007  Actinic keratosis treatment
0,224  0,013  UGT2B1 substrate
0,290  0,081  Interleukin 2 agonist
0,237  0,029  Antiviral (Influenza A)
0,244  0,037  Nitric-oxide synthase stimulant
0,335  0,129  Calcium channel L-type activator
0,252  0,045  Antiviral (Influenza)
0,302  0,096  Vasodilator, peripheral
0,316  0,113  CYP2C19 inhibitor
0,218  0,015  Sulfotransferase substrate
0,265  0,063  Cardiodepressant
0,205  0,004  UGT2B11 substrate
0,226  0,032  Succinate dehydrogenase inhibitor
0,217  0,024  Psychosexual dysfunction treatment
0,206  0,014  Growth stimulant
0,218  0,029  Genotoxic
0,200  0,014  Androgen antagonist
0,236  0,050  Peroxidase inhibitor
0,199  0,014  Contraceptive female
0,238  0,054  VCAM1 expression inhibitor
0,202  0,021  Antihemorrhagic
0,184  0,005  Ca2+-transporting ATPase inhibitor
0,257  0,079  Radiosensitizer
0,261  0,086  Radioprotector
0,214  0,038  Prostate disorders treatment
0,216  0,041  Heat shock protein 90 alpha antagonist
0,207  0,032  ATPase inhibitor
0,182  0,007  Anabolic
0,178  0,005  CC chemokine 6 receptor antagonist
0,230  0,058  Wound healing agent
0,243  0,073  Angiogenesis stimulant
0,183  0,013  Triose-phosphate isomerase inhibitor
0,194  0,025  CF transmembrane conductance regulator agonist
0,197  0,027  Glutathione S-transferase substrate
0,177  0,010  Postmenopausal disorders treatment
0,258  0,093  Immunostimulant
0,247  0,083  Gastrin inhibitor
0,190  0,027  Cystathionine beta-synthase inhibitor
0,167  0,009  Alcohol oxidase inhibitor
0,204  0,045  Antiviral (Herpes)
0,199  0,041  NOS3 expression enhancer
0,206  0,049  LDLR expression enhancer
0,174  0,018  Antispirochetal
0,175  0,019  HDL-cholesterol increasing
0,200  0,044  Phospholipase C inhibitor
0,197  0,045  Amylase inhibitor
0,193  0,042  Uterine stimulant
0,174  0,024  Choleretic
0,167  0,018  Creatine kinase inhibitor
0,155  0,006  Glycine receptor agonist
0,178  0,031  Adenylate cyclase inhibitor
0,159  0,013  Keratolytic
0,193  0,047  Hair growth stimulant
0,148  0,005  Heat shock protein 90 beta antagonist
0,219  0,077  Peptidyltransferase inhibitor
0,165  0,024  Mucolytic
0,226  0,085  Antiprotozoal (Leishmania)
0,163  0,023  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,220  0,080  Cyclic AMP phosphodiesterase inhibitor
0,168  0,030  Antiviral (Poxvirus)
0,172  0,034  Farnesoid X receptor antagonist
0,153  0,017  NADH dehydrogenase inhibitor
0,165  0,031  Pregnane X receptor agonist
0,160  0,025  Antineoplastic, alkylator
0,235  0,101  Antineoplastic (melanoma)
0,166  0,032  Carcinogenic, group 2B
0,162  0,031  Expectorant
0,154  0,025  Adenylate kinase inhibitor
0,292  0,164  Alpha-glucosidase inhibitor
0,142  0,014  Ornithine decarboxylase inhibitor
0,159  0,033  Coagulant
0,157  0,031  GABA C receptor agonist
0,165  0,040  Aldehyde dehydrogenase inhibitor
0,159  0,034  Ferrochelatase inhibitor
0,143  0,019  Phosphofructokinase-1 inhibitor
0,135  0,012  ATPase (Vacuolar H+) inhibitor
0,192  0,069  VEGF expression inhibitor
0,154  0,031  Alcohol dehydrogenase substrate
0,214  0,092  Antineoplastic (glioma)
0,132  0,011  Na+ K+ transporting ATPase inhibitor
0,168  0,050  Mannose-6-phosphate isomerase inhibitor
0,150  0,032  Antiviral (Papilloma)
0,244  0,126  Antiallergic
0,135  0,021  SULT1E1 substrate
0,162  0,048  Skin whitener
0,169  0,057  Carcinogenic, group 1
0,126  0,015  Bile acid receptor antagonist
0,136  0,025  GST T1-1 substrate
0,150  0,040  Antineoplastic antimetabolite
0,114  0,004  Postcoital contraceptive
0,120  0,011  Anticholelithogenic
0,119  0,010  Androgen agonist
0,143  0,035  Photosensitizer
0,139  0,032  Antifungal (Pneumocystis)
0,120  0,013  SULT1A2 substrate
0,110  0,004  Adenylate cyclase 1 inhibitor
0,165  0,059  Lipid peroxidase inhibitor
0,137  0,031  Estrogen antagonist
0,155  0,051  Antiseptic
0,143  0,039  Endometrios treatment
0,207  0,103  Antiviral (West Nile virus)
0,117  0,015  Cushing's syndrome treatment
0,134  0,032  DOPA decarboxylase inhibitor
0,107  0,006  SULT2A1 substrate
0,139  0,038  Antiviral (Influenza B)
0,126  0,027  Paget's disease treatment
0,118  0,019  Glycine receptor antagonist
0,148  0,050  DNA polymerase I inhibitor
0,158  0,061  Antiparkinsonian, tremor relieving
0,145  0,049  Monophenol monooxygenase inhibitor
0,116  0,020  Estrogen receptor alpha antagonist
0,148  0,054  Toll-Like receptor 2 antagonist
0,097  0,004  Pregnane X receptor antagonist
0,141  0,049  Vanilloid 1 agonist
0,145  0,053  Antihyperlipoproteinemic
0,145  0,053  Cyclooxygenase 3 inhibitor
0,195  0,104  Antineoplastic (cervical cancer)
0,103  0,012  Antimycoplasmal
0,119  0,029  Antidote, mercury
0,107  0,017  Argininosuccinate synthase inhibitor
0,120  0,031  Estrogen receptor beta antagonist
0,165  0,076  Growth hormone agonist
0,105  0,019  Estrogen-related receptor beta agonist
0,103  0,017  Biliverdin reductase inhibitor
0,186  0,100  Antialcoholic
0,126  0,044  AMP-activated protein kinase stimulant
0,104  0,022  Narcotic antagonist
0,088  0,007  RNA-directed RNA polymerase stimulant
0,166  0,087  Diabetic nephropathy treatment
0,164  0,086  Phobic disorders treatment
0,105  0,028  Antiviral (Hepatitis A)
0,087  0,010  Calcium channel P-type blocker
0,086  0,010  Lipocortins synthesis agonist
0,149  0,073  Antidote
0,097  0,022  Carbamoyl phosphate synthetase inhibitor
0,108  0,033  Porphobilinogen synthase inhibitor
0,087  0,014  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,142  0,069  Heat shock protein 70 antagonist
0,085  0,013  Sphingosine kinase inhibitor
0,173  0,101  Antineoplastic (glioblastoma multiforme)
0,135  0,063  Retinoprotector
0,139  0,068  Anesthetic
0,094  0,022  Antidote, organophosphates
0,103  0,033  Antibiotic
0,100  0,031  Glutamate dehydrogenase inhibitor
0,160  0,091  Toxic, respiratory center
0,104  0,035  Tocolytic
0,086  0,018  Glutamate (mGluR6) antagonist
0,087  0,021  Purinergic P2X1 antagonist
0,147  0,082  Aldose reductase substrate
0,075  0,010  Glucose-6-phosphate isomerase inhibitor
0,109  0,045  mTOR complex 1 inhibitor
0,105  0,043  Potassium channel activator
0,082  0,021  Acyl-CoA dehydrogenase inhibitor
0,077  0,017  Heme oxygenase stimulant
0,127  0,068  Antineoplastic (uterine cancer)
0,120  0,061  Interleukin 8 antagonist
0,072  0,013  Aldosterone antagonist
0,072  0,014  Anesthetic inhalation
0,091  0,034  GABA aminotransferase inhibitor
0,205  0,148  Metabolic disease treatment
0,080  0,023  Antiviral (Parainfluenza)
0,123  0,065  Alkylator
0,078  0,021  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,065  0,008  Guanylate cyclase inhibitor
0,272  0,216  Antineoplastic (solid tumors)
0,176  0,120  Platelet antagonist
0,090  0,036  Glutamate decarboxylase inhibitor
0,160  0,106  Sepsis treatment
0,156  0,102  Antineoplastic (bone cancer)
0,163  0,109  CYP2B6 inhibitor
0,099  0,047  Carcinogenic, group 2A
0,062  0,009  Antihyperaldosteronism
0,113  0,060  Excitatory amino acid transporter EAAC1 inhibitor
0,062  0,010  Glucocorticoid antagonist
0,060  0,009  Hypogonadism treatment
0,094  0,045  Transcription factor NF kappa B stimulant
0,084  0,034  Vanilloid 4 agonist
0,056  0,006  Tubulin agonist
0,111  0,062  GABA C receptor antagonist
0,107  0,058  Antihypermotility
0,091  0,043  NAD(P)H dehydrogenase (quinone) inhibitor
0,054  0,006  ATP citrate lysase inhibitor
0,151  0,104  Antineoplastic (gastric cancer)
0,138  0,091  Raynaud's phenomenon treatment
0,089  0,042  Antiviral (Dengue virus)
0,060  0,014  Microtubule stabilization
0,117  0,073  M18 aspartyl aminopeptidase inhibitor
0,091  0,046  Inducible nitric-oxide synthase inhibitor
0,112  0,068  TRPA1 agonist
0,084  0,040  Histidine decarboxylase inhibitor
0,148  0,104  Aldehyde oxidase substrate
0,068  0,025  Protein 50S ribosomal subunit inhibitor
0,057  0,015  Thymidine kinase inhibitor
0,086  0,044  Interferon agonist
0,057  0,015  Progesterone antagonist
0,064  0,022  Alpha-mannosidase inhibitor
0,143  0,102  Hearing loss treatment
0,168  0,128  Antiviral (HIV)
0,047  0,009  Cholesterol ester transfer protein antagonist
0,071  0,033  Interferon inducer
0,109  0,073  Antitussive
0,063  0,028  Sphingosine kinase 2 inhibitor
0,164  0,129  Antineoplastic (lymphoma)
0,069  0,035  Aromatase inhibitor
0,093  0,060  ABCA1 expression enhancer
0,055  0,022  Estradiol 17 beta-dehydrogenase inhibitor
0,157  0,124  Insulin sensitizer
0,037  0,005  Vanilloid 2 agonist
0,037  0,006  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,062  0,031  Ryanodine receptor antagonist
0,070  0,039  MDM2 inhibitor
0,091  0,060  Glutamate release inhibitor
0,167  0,137  Antineoplastic (renal cancer)
0,071  0,041  Gaucher disease treatment
0,102  0,072  Antihelmintic (Fasciola)
0,123  0,093  Antieczematic
0,120  0,091  Antineoplastic (squamous cell carcinoma)
0,054  0,025  Mineralocorticoid receptor antagonist
0,070  0,041  Andropause treatment
0,032  0,005  Progesterone receptor B antagonist
0,030  0,004  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,028  0,003  Telomerase stimulant
0,045  0,021  Kainate receptor agonist
0,045  0,022  Sphingosine kinase 1 inhibitor
0,027  0,004  Antibiotic Anthracycline-like
0,061  0,039  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,077  0,055  MAP kinase kinase 7 inhibitor
0,083  0,061  mTOR complex 2 inhibitor
0,049  0,027  Mannosidase inhibitor
0,072  0,051  Aminopeptidase I inhibitor
0,028  0,007  Progesterone agonist
0,029  0,009  GRP78 expression inhibitor
0,052  0,032  Potassium channel (Inward rectifier) activator
0,128  0,107  Hexokinase inhibitor
0,054  0,033  Estrogen agonist
0,064  0,044  Transcription factor RelA inhibitor
0,051  0,031  Antiviral (Herpesvirus 3, Human)
0,085  0,065  Sodium/hydrogen exchanger 5 inhibitor
0,035  0,016  Glutamate (mGluR3) agonist
0,198  0,179  Antithrombotic
0,031  0,012  Hedgehog signaling activator
0,042  0,023  5-Alpha-reductase inhibitor
0,115  0,097  Antiprotozoal (Trichomonas)
0,049  0,031  Potassium channel Kv1.3 blocker
0,038  0,020  Fumarate hydratase inhibitor
0,081  0,063  T cell inhibitor
0,065  0,047  Uterine relaxant
0,026  0,009  Corticosteroid-like
0,067  0,050  Phenylalanine 4-hydroxylase inhibitor
0,049  0,032  Potassium channel (ATP-sensitive) activator
0,103  0,087  Autism spectrum disorders treatment
0,055  0,039  Dihydroorotate oxidase inhibitor
0,052  0,036  Aconitate hydratase inhibitor
0,091  0,075  Tourette's syndrome treatment
0,032  0,016  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,037  0,022  Retinoid X alpha receptor agonist
0,039  0,024  Vanilloid 3 antagonist
0,032  0,017  Uridine phosphorylase inhibitor
0,160  0,145  Antipyretic
0,089  0,074  Lanosterol 14 alpha demethylase inhibitor
0,085  0,071  HIV-1 integrase (Overall Integration) inhibitor
0,040  0,026  Retinoic acid alpha receptor agonist
0,085  0,071  Thioredoxin inhibitor
0,065  0,052  Antihemophilic
0,042  0,029  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,038  0,025  Glutamate (mGluR8) agonist
0,025  0,012  Prostaglandin F2 alpha agonist
0,038  0,025  Delayed rectifier potassium channel blocker
0,038  0,026  Potassium channel Kv1.1 blocker
0,120  0,108  Antiprotozoal (Coccidial)
0,038  0,026  Glucose-6-phosphate dehydrogenase inhibitor
0,029  0,018  Purinergic P2Y15 antagonist
0,034  0,023  Sodium-dependent vitamin C transporter 2 inhibitor
0,088  0,077  Carbonic anhydrase III inhibitor
0,039  0,029  Dopamine D5 agonist
0,098  0,088  Electron transport complex I inhibitor
0,032  0,022  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,017  0,007  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,069  0,059  CDC25A inhibitor
0,140  0,131  Non-steroidal antiinflammatory agent
0,017  0,008  Thromboxane A2 agonist
0,033  0,024  Estrogen receptor alpha agonist
0,082  0,074  Antischistosomal
0,013  0,005  Thromboxane agonist
0,048  0,039  Squalene epoxidase inhibitor
0,087  0,079  Electrolyte absorption antagonist
0,087  0,079  Antithrombocytopenic
0,092  0,084  Beta glucuronidase inhibitor
0,013  0,006  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,123  0,116  Prostatic (benign) hyperplasia treatment
0,124  0,117  GABA C receptor rho-2 antagonist
0,072  0,065  Antitreponemal
0,011  0,005  Progesterone receptor A antagonist
0,214  0,208  Antineoplastic (small cell lung cancer)
0,029  0,024  Estrogen receptor beta agonist
0,008  0,003  Transcortin receptor antagonist
0,043  0,038  Parathyroid hormone antagonist
0,210  0,206  Antineoplastic (non-Hodgkin's lymphoma)
0,025  0,022  Sodium/glucose cotransporter 2 inhibitor
0,049  0,046  Nicotinic alpha3beta2 receptor antagonist
0,064  0,061  Arylamine N-Acetyltransferase substrate
0,087  0,084  GABA C receptor rho-1 antagonist
0,020  0,018  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,177  0,176  12-Lipoxygenase inhibitor
0,030  0,029  Retinoid X receptor agonist
0,017  0,016  Methylmalonyl-CoA mutase inhibitor
0,019  0,018  Retinoid X beta receptor antagonist
0,065  0,065  NAT1 substrate
0,082  0,082  Anticataract
0,015  0,015  Vitamin D receptor agonist

